Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-de-based quantitative proteomics

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Madeira, Andreia ^a   da Silva, Cláudia L ^a   dos Santos, Francisco ^a   Camafeita, Emilio ^b   Cabral, Joaquim M S ^a   Sá Correia, Isabel ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; BETA ACTIN; CELL CYCLE PROTEIN; CHAPERONE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; CYTOKERATIN 1; CYTOKERATIN 2; CYTOSKELETON PROTEIN; GLUCOSE REGULATED PROTEIN; HEAT SHOCK PROTEIN; LAMIN A; LIPOCORTIN 1; STRUCTURAL PROTEIN; VIMENTIN;

ARTICLE; CELL AGING; CELL CULTURE; CELL PROLIFERATION; CELL STRESS; CLONOGENESIS; CYTOSKELETON; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; STEM CELL EXPANSION; TWO DIMENSIONAL ELECTROPHORESIS;

CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MESENCHYMAL STROMAL CELLS; PROTEOMICS;

EID: 84865185516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043523     Document Type: Article

References (65)

1. Mimeault M, Hauke R, Batra SK, ((2007)) Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82:: 252--264.
2. Blanc KL, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. ((2008)) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:: 1579--1586.
3. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, et al. ((2002)) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 99:: 8932--8937.
4. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, et al. ((2009)) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:: 2277--2286.
5. Tyndall A, Uccelli A, ((2009)) Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplant 43:: 821--828.
6. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, et al. ((2006)) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:: 1390--1397.
7. Dominici M, Blanc KL, Mueller I, Slaper-Cortenbach I, Marini F, et al. ((2006)) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytother 8:: 315--317.
8. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, et al. ((2006)) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:: 14.
9. Sensebé L, Bourin P, Tarte K, ((2011)) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22:: 19--26.
10. Kim J, Kang JW, Park JH, Choi Y, Choi KS, et al. ((2009)) Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 32:: 117--126.
11. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. ((2008)) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3:: e2213.
12. Kim JS, Kim EJ, Kim HJ, Yang JY, Hwang GS, et al. ((2011)) Proteomic and metabolomic analysis of H2O2-induced premature senescent human mesenchymal stem cells. Exp Gerontol 46:: 500--510.
13. Feldmann REJ, Bieback K, Maurer MH, Kalenka A, Bürgers HF, et al. ((2005)) Stem cell proteomes: A profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 26:: 2749--2758.
14. Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, et al. ((2005)) Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:: 1367--1377.
15. Sá-Correia I, Teixeira MC, ((2010)) 2D electrophoresis-based expression proteomics: a microbiologist's perspective. Expert Rev Proteomics 7:: 943--953.
16. dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, et al. ((2010)) Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 223:: 27--35.
17. Eibes G, Santos Fd, Andrade PZ, Boura JS, Abecasis MM, et al. ((2010)) Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146:: 194--197.
18. dos Santos F, Andrade PZ, Eibes G, da Silva CL, Cabral JM, ((2011)) Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol 698:: 189--198.
19. Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, et al. ((2011)) The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng A 17:: 2221--2230.
20. Santos PM, Sá-Correia I, ((2009)) Adaptation to beta-myrcene catabolism in Pseudomonas sp. M1: an expression proteomics analysis. PROTEOMICS 9:: 5101--5111.
21. Santos PM, Simões T, Sá-Correia I, ((2009)) Insights into yeast adaptive response to the agricultural fungicide mancozeb: A toxicoproteomics approach. PROTEOMICS 9:: 657--670.
22. Madeira A, Santos PM, Coutinho CP, Pinto-de-Oliveira A, Sá-Correia I, ((2011)) Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. PROTEOMICS 11:: 1313--1328.
23. Wagner W, Ho AD, Zenke M, ((2010)) Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16:: 445--453.
24. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. ((1999)) Multilineage potential of adult human mesenchymal stem cells. Science 284:: 143--147.
25. Zhou Z, Kahns S, Nielsen A, ((2010)) Identification of a novel vimentin promoter and mRNA isoform. Mol Biol Rep 37:: 2407--2413.
26. Eriksson JE, He T, Trejo-Skalli AV, Harmala-Brasken AS, Hellman J, et al. ((2004)) Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci 117:: 919--932.
27. Ivaska J, Pallari H, Nevo J, Eriksson JE, ((2007)) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313:: 2050--2062.
28. Tsuruta D, Jones JC, ((2003)) The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress. J Cell Sci 116:: 4977--4984.
29. Bershadsky AD, Balaban NQ, Geiger B, ((2003)) Adhesion-dependent cell mechanosensitivity. Annu Rev Cell Dev Biol 19:: 677--695.
30. Kregel KC, ((2002)) Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 92:: 2177--2186.
31. Tsukahara F, Yoshioka T, Muraki T, ((2000)) Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70. Mol Pharmacol 58:: 1257--1263.
32. Bukau B, Horwich AL, ((1998)) The Hsp70 and Hsp60 chaperone machines. Cell 92:: 351--366.
33. Wagner W, Bork S, Horn P, Krunic D, Walenda T, et al. ((2009)) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE 4:: e5846.
34. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, ((1996)) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:: 147--157.
35. Dell'Orco RT, McClung JK, Jupe ER, Liu XT, ((1996)) Prohibitin and the senescent phenotype. Exp Gerontol 31:: 245--252.
36. Nijtmans LG, Artal SM, Grivell LA, Coates PJ, ((2002)) The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci 59:: 143--155.
37. Chowdhury I, Xu W, Stiles JK, Zeleznik A, Yao X, et al. ((2007)) Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Endocrinol 148:: 206--217.
38. Sunaga K, Takahashi H, Chuang DM, Ishitani R, ((1995)) Glyceraldehyde-3-phosphate dehydrogenase is over-expressed during apoptotic death of neuronal cultures and is recognized by a monoclonal antibody against amyloid plaques from Alzheimer's brain. Neurosci Lett 200:: 133--136.
39. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, et al. ((1996)) Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 66:: 928--935.
40. Schroder M, Kaufman RJ, ((2005)) ER stress and the unfolded protein response. Mutat Res 569:: 29--63.
41. Levchenko A, ((2005)) Proteomics takes stem cell analyses to another level. Nat Biotechnol 23:: 828--830.
42. Kasper G, Mao L, Geissler S, Draycheva A, Trippens J, et al. ((2009)) Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27:: 1288--1297.
43. Kindas-Mugge I, Micksche M, Trautinger F, ((1998)) Modification of growth in small heat shock (hsp27) gene transfected breast carcinoma. Anticancer Res 18:: 413--417.
44. Stolzing A, Jones E, McGonagle D, Scutt A, ((2008)) Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129:: 163--173.
45. O'Callaghan-Sunol C, Gabai VL, Sherman MY, ((2007)) Hsp27 modulates p53 signaling and suppresses cellular senescence. Cancer Res 67:: 11779--11788.
46. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, et al. ((2000)) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2:: 645--652.
47. Meunier L, Usherwood YK, Chung KT, Hendershot LM, ((2002)) A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol Biol Cell 13:: 4456--4469.
48. Hoglinger GU, Carrard G, Michel PP, Medja F, Lombes A, et al. ((2003)) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J Neurochem 86:: 1297--1307.
49. Aravind L, Ponting CP, ((1998)) Homologues of 26S proteasome subunits are regulators of transcription and translation. Protein Sci 7:: 1250--1254.
50. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, et al. ((2006)) Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 25:: 4923--4936.
51. Haynes CM, Titus EA, Cooper AA, ((2004)) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol Cell 15:: 767--776.
52. Rattan SI, Clark BF, ((2005)) Understanding and modulating ageing. IUBMB Life 57:: 297--304.
53. Alldridge LC, Bryant CE, ((2003)) Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 290:: 93--107.
54. Engeland M, Ramaekers FC, Schutte B, Reutelingsperger CP, ((1996)) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24:: 131--139.
55. Kapiszewska M, Reddy NM, Lange CS, ((1991)) Trypsin-induced changes in cell shape and chromatin structure result in radiosensitization of monolayer Chinese hamster V79 cells. Int J Radiat Biol 60:: 635--646.
56. Huang HL, Hsing HW, Lai TC, Chen YW, Lee TR, et al. ((2010)) Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 17:: 36.
57. Shin BK, Wang H, Yim AM, Naour FL, Brichory F, et al. ((2003)) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 278:: 7607--7616.
58. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A, ((2007)) GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8:: R3.
59. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, et al. ((2009)) GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 37:: W317--W322.
60. Izzo MW, Strachan GD, Stubbs MC, Hall DJ, ((1999)) Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ. J Biol Chem 274:: 19498--19506.
61. Dang CV, Resar LM, Emison E, Kim S, Li Q, et al. ((1999)) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253:: 63--77.
62. Li L, He S, Sun JM, Davie JR, ((2004)) Gene regulation by Sp1 and Sp3. Biochem Cell Biol 82:: 460--471.
63. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, ((2007)) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protocols 1:: 2856--2860.
64. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, et al. ((2003)) A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal Bioanal Chem 376:: 952--965.
65. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS, ((1999)) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electroph 20:: 3551--3567.